Acumen Diagnostics, a 51%-owned subsidiary of Q&M Dental Group and 49%-owned by Aoxin Q&M Dental Group, says it has been granted a license by the Ministry of Health (MOH) to provide offsite Covid-19 polymerase chain reaction (PCR) swab services and serology sample collection.

Acumen Diagnostics will roll out its testing services via Q&M Dental’s clinics, as well as its headquarters at The Gemini at 41 Science Park.

With the onset of the Omicron variant and the opening of the vaccinated travel lane (VTL) arrangements, the company will increase its Covid-19 PCR testing services to include 10 Q&M Dental clinics by Dec 31.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook